Download PDF
Int J Angiol 2022; 31(03): 194-197
DOI: 10.1055/s-0042-1756176
Invited Article

Management of Massive Pulmonary Embolism

Eva Polaková 
1   Department of Cardiology, Second Medical School, Charles University, Motol University Hospital, Prague, Czech Republic
,
Josef Veselka
1   Department of Cardiology, Second Medical School, Charles University, Motol University Hospital, Prague, Czech Republic
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Pulmonary embolism is a potentially lethal manifestation of venous thromboembolic disease. It is one of the three main causes of cardiovascular morbidity and mortality in developed countries. Over the years, better diagnostic and risk stratification measures were implemented. A generous range of new treatment options is becoming available, particularly for management of massive pulmonary embolism. Nonetheless, clinicians often face uncertainty in clinical practice due to lack of scientific support for available treatment options. The aim of this article is to review management of massive pulmonary embolism.

Keywords

pulmonary embolism - massive pulmonary embolism - high-risk pulmonary embolism - reperfusion treatment - thrombolysis - embolectomy - ECMO


Publication History

Article published online:
23 September 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Smith SB, Geske JB, Kathuria P. et al. Analysis of national trends in admissions for pulmonary embolism. Chest 2016; 150 (01) 35-45
    CrossrefPubMedGoogle Scholar
  • 2 Raskob GE, Angchaisuksiri P, Blanco AN. et al. Thrombosis: a major contributor to global disease burden. J Thromb Haemost 2014; 12 (10) 1580-1590
    CrossrefPubMedGoogle Scholar
  • 3 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J 2020; 41 (Suppl. 04) 543-603
    Google Scholar
  • 4 Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121 (3, suppl): 877-905
    CrossrefPubMedGoogle Scholar
  • 5 Rivera-Lebron B, McDaniel M, Ahrar K. et al; PERT Consortium. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT Consortium. Clin Appl Thromb Hemost 2019; 25: 1076029619853037
    Google Scholar
  • 6 Jaff MR, McMurtry MS, Archer SL. et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, American Heart Association Council on Peripheral Vascular Disease, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
    CrossrefPubMedGoogle Scholar
  • 7 Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest 2010; 137 (06) 1382-1390
    CrossrefPubMedGoogle Scholar
  • 8 Bhat T, Neuman A, Tantary M. et al. Inhaled nitric oxide in acute pulmonary embolism: a systematic review. Rev Cardiovasc Med 2015; 16 (01) 1-8
    CrossrefPubMedGoogle Scholar
  • 9 Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc 2014; 11 (05) 811-822
    CrossrefPubMedGoogle Scholar
  • 10 Lyhne MD, Dragsbaek SJ, Hansen JV, Schultz JG, Andersen A, Nielsen-Kudsk JE. Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism. Pulm Circ 2021;11(03):20458940211022977
    PubMedGoogle Scholar
  • 11 Stevens SM, Woller SC, Kreuziger LB. et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest 2021; 160 (06) e545-e608
    CrossrefPubMedGoogle Scholar
  • 12 Goldhaber SZ, Haire WD, Feldstein ML. et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341 (8844): 507-511
    CrossrefPubMedGoogle Scholar
  • 13 Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, Kasper W. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998; 82 (08) 966-970
    CrossrefPubMedGoogle Scholar
  • 14 Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997; 80 (02) 184-188
    Google Scholar
  • 15 Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358 (10) 1037-1052
    CrossrefPubMedGoogle Scholar
  • 16 McFadden PM, Ochsner JL. Aggressive approach to pulmonary embolectomy for massive acute pulmonary embolism: a historical and contemporary perspective. Mayo Clin Proc 2010; 85 (09) 782-784
    CrossrefPubMedGoogle Scholar
  • 17 Goldberg JB, Spevack DM, Ahsan S. et al. Survival and right ventricular function after surgical management of acute pulmonary embolism. J Am Coll Cardiol 2020; 76 (08) 903-911
    CrossrefPubMedGoogle Scholar
  • 18 Pasrija C, Kronfli A, Rouse M. et al. Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: A single-center experience. J Thorac Cardiovasc Surg 2018; 155 (03) 1095-1106.e2
    CrossrefPubMedGoogle Scholar
  • 19 Neely RC, Byrne JG, Gosev I. et al. Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients. Ann Thorac Surg 2015; 100 (04) 1245-1252
    CrossrefPubMedGoogle Scholar
  • 20 Giri J, Sista AK, Weinberg I. et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the american heart association. Circulation 2019; 140 (20) e774-e801
    Google Scholar
  • 21 Teleb M, Porres-Aguilar M, Rivera-Lebron B. et al. Ultrasound-assisted catheter-directed thrombolysis: a novel and promising endovascular therapeutic modality for intermediate-risk pulmonary embolism. Angiology 2017; 68 (06) 494-501
    CrossrefPubMedGoogle Scholar
  • 22 Avgerinos ED, Jaber W, Lacomis J. et al; SUNSET sPE Collaborators. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the SUNSET sPE Trial. JACC Cardiovasc Interv 2021; 14 (12) 1364-1373
    Google Scholar
  • 23 Sista AK. Is it time to sunset ultrasound-assisted catheter-directed thrombolysis for submassive PE?. JACC Cardiovasc Interv 2021; 14 (12) 1374-1375
    CrossrefPubMedGoogle Scholar
  • 24 Aso S, Matsui H, Fushimi K, Yasunaga H. In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan. Crit Care 2016; 20 (01) 80
    CrossrefPubMedGoogle Scholar
  • 25 Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review. Perfusion 2015; 30 (08) 611-616
    CrossrefPubMedGoogle Scholar
  • 26 Meneveau N, Guillon B, Planquette B. et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 2018; 39 (47) 4196-4204
    CrossrefPubMedGoogle Scholar
  • 27 George B, Parazino M, Omar HR. et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 2018; 122: 1-5
    CrossrefPubMedGoogle Scholar
  • 28 Ghoreishi M, DiChiacchio L, Pasrija C. et al. Predictors of recovery in patients supported with venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism. Ann Thorac Surg 2020; 110 (01) 70-75
    CrossrefPubMedGoogle Scholar
  • 29 Kapur NK, Esposito ML, Bader Y. et al. Mechanical circulatory support devices for acute right ventricular failure. Circulation 2017; 136 (03) 314-326
    CrossrefPubMedGoogle Scholar
  • 30 Porres-Aguilar M, Anaya-Ayala JE, Jiménez D, Mukherjee D. Pulmonary embolism response teams: pursuing excellence in the care for venous thromboembolism. Arch Med Res 2019; 50 (05) 257-258
    CrossrefPubMedGoogle Scholar